A CxxC domain that binds to unmethylated CpG is required for KDM2A to control rDNA transcription

Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan
Makoto TsuneokaKengo Okamoto

Abstract

Dysfunction of ribosome biogenesis is commonly found in cancers. Because the transcription of ribosomal RNA genes (rDNA) is a rate-limiting step in ribosome biogenesis and is elevated in many cancer cells, ribosomal RNA transcription can be a target for cancer therapy. In eukaryotes, ribosomal RNA is transcribed specifically in nucleoli by RNA polymerase I but not by RNA polymerase II. Therefore, ribosomal RNA transcription by RNA polymerase I would have a distinct nature compared to transcription by RNA polymerase II. Genomic DNA with proteins including histones constitutes chromatin. The structure of chromatin has plasticity and is regulated by chemical modifications of chromatin's components. We had reported that histone demethylase KDM2A reduced ribosomal RNA transcription in response to starvation. In this symposium, we reported our recent results showing the mechanism by which KDM2A was recruited to rDNA chromatin. We found that KDM2A bound to a rDNA promoter with unmethylated CpG dinucleotides via KDM2A CxxC-zinc finger motif. This binding was required for KDM2A to demethylate histone in the rDNA promoter and reduce rDNA transcription resulting from starvation. Further, this binding was detected before starvation, indepe...Continue Reading

References

Jul 20, 1987·Journal of Molecular Biology·M Gardiner-Garden, M Frommer
Feb 13, 1999·Nature Genetics·N DraptchinskaiaN Dahl
Dec 24, 2002·Nature Genetics·Graeme R B BoocockJohanna M Rommens
Feb 27, 2007·Cell·Tony Kouzarides
Feb 24, 2009·Nature Reviews. Molecular Cell Biology·Aline V ProbstGeneviève Almouzni
Sep 10, 2009·Cancer Research·Denis DryginWilliam G Rice
Mar 3, 2010·Blood·Anupama Narla, Benjamin L Ebert
Mar 20, 2010·Nature Reviews. Genetics·Raphaël Margueron, Danny Reinberg
Apr 10, 2010·The EMBO Journal·Yuji TanakaMakoto Tsuneoka
Apr 27, 2010·Molecular Cell·Neil P BlackledgeRobert J Klose
Oct 12, 2010·Epigenetics : Official Journal of the DNA Methylation Society·Neil P Blackledge, Robert Klose
May 18, 2011·Genes & Development·Aimée M Deaton, Adrian Bird
Apr 5, 2012·Nature Reviews. Molecular Cell Biology·Susanne Marije Kooistra, Kristian Helin
Jun 26, 2012·Journal of Medicinal Chemistry·Nathan R RoseAkane Kawamura
Apr 25, 2013·Nature Reviews. Cancer·Megan J BywaterRoss D Hannan
May 24, 2013·Biochemical Society Transactions·Hannah K LongRobert J Klose
Aug 24, 2013·Journal of Medicinal Chemistry·Takayoshi SuzukiNaoki Miyata
Feb 21, 2014·Cell Structure and Function·Yuji TanakaMakoto Tsuneoka

❮ Previous
Next ❯

Citations

Apr 15, 2016·International Journal of Cardiology·Xiyang PengYun Deng

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.